RxDoctor Payments Data

Chad McCall

Anatomic Pathology & Clinical Pathology · Charlotte, NCNPI 1326278532

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,932 of the $2,797 with a category attached, or 69.1%. E.r. Squibb & Sons, L.L.C. accounts for 69.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $1,947 and has fallen 98.6% since, to $28 in 2025. Among anatomic pathology & clinical pathology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,797in general payments, 2019–2025

Across 13 payments — averaging $215.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$2K
  • BD$454
  • Sysmex America, Inc.$208
  • Davol Inc.$111
  • Novartis$28
  • Adaptive Biotechnologies Corporation$20
  • plus $45 from 3 others

What the payments were for

  • Consulting fees$1,93269%
  • Food & beverage$86531%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,797 in reported general payments places this provider in the 90th percentile of 221 anatomic pathology & clinical pathology providers in North Carolina.

See all anatomic pathology & clinical pathology providers in North Carolina

Medicare billing

Part B allowed, 2024
$197,678
Medicare patients
1,887
Services billed
7,466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →